Gene · 406978
Papers1,393
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,393
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In silico whole-transcriptome analysis reveals a potential hsa_circ_0000375-miR-424-5p-TPM2/SRPX/SRGAP1 regulatory network related to liver metastasis of colorectal cancer. | Heliyon | 2023 | 37954397 | PubTator, text mining | PubMed |
| MicroRNA and Protein Cargos of Human Limbal Epithelial Cell-Derived Exosomes and Their Regulatory Roles in Limbal Stromal Cells of Diabetic and Non-Diabetic Corneas. | Cells | 2023 | 37947602 | PubTator, text mining | PubMed |
| Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6. | J Ovarian Res | 2023 | 37940982 | PubTator, text mining | PubMed |
| Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer. | Sci Rep | 2023 | 37935712 | PubTator, text mining | PubMed |
| Circulating levels of miR125a, miR126, and miR146a-5p in patients with obstructive sleep apnea and their relation with markers of endothelial dysfunction. | PLoS One | 2023 | 37917636 | PubTator, text mining | PubMed |
| Analysis of miRNAs in Osteogenesis imperfecta Caused by Mutations in COL1A1 and COL1A2: Insights into Molecular Mechanisms and Potential Therapeutic Targets. | Pharmaceuticals (Basel) | 2023 | 37895885 | PubTator, text mining | PubMed |
| Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients. | Bioengineering (Basel) | 2023 | 37892917 | PubTator, text mining | PubMed |
| Role of the Circadian Gas-Responsive Hemeprotein NPAS2 in Physiology and Pathology. | Biology (Basel) | 2023 | 37887064 | PubTator, text mining | PubMed |
| Identification of asthma-related genes using asthmatic blood eQTLs of Korean patients. | BMC Med Genomics | 2023 | 37875944 | PubTator, text mining | PubMed |
| miR-199a and miR-199b facilitate diffuse gastric cancer progression by targeting Frizzled-6. | Sci Rep | 2023 | 37838767 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Triple-Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential. | Cancers (Basel) | 2023 | 37835573 | PubTator, text mining | PubMed |
| Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy. | Sci Rep | 2023 | 37821628 | PubTator, text mining | PubMed |
| m6A-Modified circTET2 Interacting with HNRNPC Regulates Fatty Acid Oxidation to Promote the Proliferation of Chronic Lymphocytic Leukemia. | Adv Sci (Weinh) | 2023 | 37821382 | PubTator, text mining | PubMed |
| Rejuvenation of Senescent Mesenchymal Stem Cells to Prevent Age-Related Changes in Synovial Joints. | Cell Transplant | 2023 | 37766590 | PubTator, text mining | PubMed |
| Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology Techniques. | Cancers (Basel) | 2023 | 37760539 | PubTator, text mining | PubMed |
| Recent advances in exosomal non-coding RNA-based therapeutic approaches for photoaging. | Skin Res Technol | 2023 | 37753673 | PubTator, text mining | PubMed |
| Idiopathic inflammatory myopathy and non-coding RNA. | Front Immunol | 2023 | 37744337 | PubTator, text mining | PubMed |
| Cell-free therapy based on extracellular vesicles: a promising therapeutic strategy for peripheral nerve injury. | Stem Cell Res Ther | 2023 | 37726794 | PubTator, text mining | PubMed |
| Prognostic model of kidney renal clear cell carcinoma using aging-related long noncoding RNA signatures identifies THBS1-IT1 as a potential prognostic biomarker for multiple cancers. | Aging (Albany NY) | 2023 | 37708239 | PubTator, text mining | PubMed |
| miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach. | Int J Mol Sci | 2023 | 37686073 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406978/papers?page=3